retatrutide nonalcoholic fatty liver disease trial nash A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis Resmetirom and Thyroid Hormone Receptor‐Targeted
Pay in 4 interest-free payments of $5.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13






















